Dogwood Therapeutics Registers 4.1 Million Shares for Sale
Dogwood Therapeutics has filed to sell 4.1 million shares of common stock to strengthen its financial position amid ongoing drug development efforts.
Royal Bank of Canada files for market-linked securities offering
Royal Bank of Canada has filed a registration statement for market-linked securities linked to the EURO STOXX 50 Index, enhancing its investment offerings.
Accuray Inc Files Registration Statement for Stock Options
Accuray Inc has filed a registration statement for stock options under its employee benefit plan, enhancing its talent retention strategy.
Benchmark 2026-B43 Mortgage Trust files ABS-EE report
Benchmark 2026-B43 Mortgage Trust has filed an ABS-EE report detailing its commercial mortgage-backed securities, indicating ongoing activity in the sector.
JPMorgan Chase Financial Co. issues contingent interest notes
JPMorgan Chase Financial Co. LLC has announced new callable contingent interest notes linked to major indices, enhancing its product offerings.
HSBC USA Inc. Offers New Autocallable Income Notes
HSBC USA Inc. files a prospectus for Autocallable Contingent Income Barrier Notes, reflecting its strategy in the national commercial banking sector.
Bambusa Therapeutics plans IPO, offering 10.6 million shares
Bambusa Therapeutics announces its IPO, offering 10.6 million shares at $16 each, marking a significant step in the biological products industry.
Morgan Stanley announces new auto-callable securities offering
Morgan Stanley has filed a free writing prospectus for its SPXF40D4 contingent income memory auto-callable securities, enhancing its product offerings.
Deutsche DWS Global/International Fund Reports Year-End Results
Deutsche DWS Global/International Fund, Inc. files its certified shareholder report, detailing financial performance for the year ending August 31, 2026.
Rycore TX Industrial Holdings announces new equity offering
Rycore TX Industrial Holdings LLC files for new equity offering, aiming to raise over $4 million to support its growth in the real estate sector.
Yury Gryzlov Files to Sell Over 10,000 Shares of Grid Dynamics
Yury Gryzlov has filed to sell more than 10,000 shares of Grid Dynamics Holdings, indicating a significant move in the prepackaged software sector.
Pzena Investment Management reports $34 billion in assets
Pzena Investment Management's latest filing shows over $34 billion in assets under management, reflecting its strong investment strategy.
Scancell Holdings Files for American Depositary Shares Registration
Scancell Holdings plc has filed a registration statement for 100 million American Depositary Shares, enhancing its U.S. market presence.
Sparrow Funds Files Post-Effective Amendment for Growth Fund
Sparrow Funds files a post-effective amendment to its registration statement, enhancing its mutual fund offerings and focusing on growth investments.
Morgan Stanley Finance LLC Files Free Writing Prospectus
Morgan Stanley Finance LLC files a free writing prospectus for its latest securities offering, signaling a strategic move in the competitive market.
Benchmark 2026-B43 Mortgage Trust Reports Stable Distribution
Benchmark 2026-B43 Mortgage Trust files distribution report with no breaches in asset representations, signaling stability in the asset-backed securities market.
Zeronda Tyler Exercises Stock Options for 156,115 Shares
Zeronda Tyler, CFO of Yarrow Bioscience, exercises stock options for 156,115 shares, reflecting executive compensation trends in the pharmaceutical sector.
Ryder Steven acquires stock options at Yarrow Bioscience
Ryder Steven, Chief Medical Officer at Yarrow Bioscience, acquires stock options, signaling confidence in the company's future growth.
Yarrow Bioscience COO Rachael Alford Acquires Stock Options
Rachael Alford, COO of Yarrow Bioscience, acquires stock options, reflecting the company's strategy to incentivize leadership in the competitive pharmaceutical sector.
Yarrow Bioscience CEO Frey Acquires 465,857 Stock Options
Rebecca Frey, CEO of Yarrow Bioscience, acquires significant stock options, reflecting confidence in the company's future and industry trends.